Publicacions en què col·labora amb ADELA CASTILLEJO CASTILLO (54)

2024

  1. Genetic and clinical characterization of a novel FH founder mutation in families with hereditary leiomyomatosis and renal cell cancer syndrome

    Orphanet Journal of Rare Diseases, Vol. 19, Núm. 1

  2. SpadaHC: a database to improve the classification of variants in hereditary cancer genes in the Spanish population

    Database : the journal of biological databases and curation, Vol. 2024

2022

  1. Lynch-like Syndrome: Potential Mechanisms and Management

    Cancers, Vol. 14, Núm. 5

2021

  1. Co-occurrence of germline pathogenic variants for different hereditary cancer syndromes in patients with Lynch syndrome

    Cancer Communications, Vol. 41, Núm. 3, pp. 218-228

2020

  1. Clinical and Pathological Characterization of Lynch-Like Syndrome

    Clinical Gastroenterology and Hepatology, Vol. 18, Núm. 2, pp. 368-374.e1

  2. Hereditary leiomyomatosis and renal cell cancer syndrome in spain: Clinical and genetic characterization

    Cancers, Vol. 12, Núm. 11, pp. 1-16

  3. Risk of cancer in family members of patients with lynch-like syndrome

    Cancers, Vol. 12, Núm. 8, pp. 1-12

2019

  1. Implementation of massive sequencing in the genetic diagnosis of hereditary cancer syndromes: Diagnostic performance in the Hereditary Cancer Programme of the Valencia Community (FamCan-NGS)

    Hereditary Cancer in Clinical Practice, Vol. 17, Núm. 1

2018

  1. A label free disposable device for rapid isolation of rare tumor cells from blood by ultrasounds

    Micromachines, Vol. 9, Núm. 3

  2. Biotecnología y biomedicina: sistema transversal de aprendizaje integrado de la ingeniería tisular

    Memorias del Programa de Redes-I3CE de calidad, innovación e investigación en docencia universitaria: Convocatoria 2017-18 (Instituto de Ciencias de la Educación), pp. 2601-2616

  3. Colorectal cancer molecular classification using BRAF, KRAS, microsatellite instability and CIMP status: Prognostic implications and response to chemotherapy

    PLoS ONE, Vol. 13, Núm. 9

  4. Primary constitutional MLH1 epimutations: a focal epigenetic event

    British Journal of Cancer, Vol. 119, Núm. 8, pp. 978-987

2017

  1. Characterization of a novel POLD1 missense founder mutation in a Spanish population

    Journal of Gene Medicine, Vol. 19, Núm. 4

  2. Grupo de Biotecnología: Utilización del microscopio virtual en la enseñanza de la Biología Celular presencial y online

    Memorias del Programa de Redes-I3CE de calidad, innovación e investigación en docencia universitaria: Convocatoria 2016-17 (Instituto de Ciencias de la Educación), pp. 2737-2749

  3. Increased Risk of Colorectal Cancer in Patients With Multiple Serrated Polyps and Their First-Degree Relatives

    Gastroenterology, Vol. 153, Núm. 1, pp. 106-112.e2

  4. Streptococcus gallolyticus infection in colorectal cancer and association with biological and clinical factors

    PLoS ONE, Vol. 12, Núm. 3

2016

  1. Inflammatory-related genetic variants in non-muscle-invasive bladder cancer prognosis: A multimarker bayesian assessment

    Cancer Epidemiology Biomarkers and Prevention, Vol. 25, Núm. 7, pp. 1144-1150

  2. Prediction of non-muscle invasive bladder cancer outcomes assessed by innovative multimarker prognostic models

    BMC Cancer, Vol. 16, Núm. 1

  3. The heritability and patterns of DNA methylation in normal human colorectum

    Human molecular genetics, Vol. 25, Núm. 12, pp. 2600-2611

2015

  1. HGUE-C-1 is an atypical and novel colon carcinoma cell line

    BMC Cancer, Vol. 15, Núm. 1